Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 15308-01-7 | MDL No. : | MFCD00437681 |
Formula : | C14H10Cl3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BPEUHDIEZQWRGC-UHFFFAOYSA-N |
M.W : | 314.59 | Pubchem ID : | 84868 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.07 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 80.71 |
TPSA : | 20.31 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.87 cm/s |
Log Po/w (iLOGP) : | 2.66 |
Log Po/w (XLOGP3) : | 4.72 |
Log Po/w (WLOGP) : | 4.9 |
Log Po/w (MLOGP) : | 4.56 |
Log Po/w (SILICOS-IT) : | 4.28 |
Consensus Log Po/w : | 4.22 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.97 |
Solubility : | 0.00339 mg/ml ; 0.0000108 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.88 |
Solubility : | 0.00419 mg/ml ; 0.0000133 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -6.43 |
Solubility : | 0.000116 mg/ml ; 0.000000368 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.21 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 13167-25-4 ]
1-(2,4,6-Trichlorophenyl)-1H-pyrrole-2,5-dione
Similarity: 0.90
[ 50610-32-7 ]
N,N'-(2-Chloro-1,4-phenylene)diacetamide
Similarity: 0.86
[ 183500-94-9 ]
1-(3-Chlorophenyl)piperazin-2-one hydrochloride
Similarity: 0.77
[ 13953-09-8 ]
N-(4-Bromo-2,6-dichlorophenyl)acetamide
Similarity: 0.77
[ 13167-25-4 ]
1-(2,4,6-Trichlorophenyl)-1H-pyrrole-2,5-dione
Similarity: 0.90
[ 50610-32-7 ]
N,N'-(2-Chloro-1,4-phenylene)diacetamide
Similarity: 0.86
[ 183500-94-9 ]
1-(3-Chlorophenyl)piperazin-2-one hydrochloride
Similarity: 0.77
[ 13953-09-8 ]
N-(4-Bromo-2,6-dichlorophenyl)acetamide
Similarity: 0.77
[ 13167-25-4 ]
1-(2,4,6-Trichlorophenyl)-1H-pyrrole-2,5-dione
Similarity: 0.90
[ 50610-32-7 ]
N,N'-(2-Chloro-1,4-phenylene)diacetamide
Similarity: 0.86
[ 183500-94-9 ]
1-(3-Chlorophenyl)piperazin-2-one hydrochloride
Similarity: 0.77
[ 13953-09-8 ]
N-(4-Bromo-2,6-dichlorophenyl)acetamide
Similarity: 0.77
[ 80484-00-0 ]
6-Chloro-1-methyl-3,4-dihydroquinoxalin-2(1H)-one
Similarity: 0.74
[ 50610-32-7 ]
N,N'-(2-Chloro-1,4-phenylene)diacetamide
Similarity: 0.86
[ 13953-09-8 ]
N-(4-Bromo-2,6-dichlorophenyl)acetamide
Similarity: 0.77
[ 3460-23-9 ]
N-(4-Bromo-2-chlorophenyl)acetamide
Similarity: 0.72